EUVIMEDEUVIMED entdecken
Open Access

Mitochondrial metabolism and signaling direct dendritic cell function in antitumor immunity

Zhiyuan You iD, Jiyeon Kim iD, Chuansheng Guo, Haoran Hu, Nicole M Chapman iD, Xiaoxi Meng iD, Hao Shi iD, Yan Wang iD, Cliff Guy iD, Anil Kc, Jia Li, Jordy Saravia iD und 4 weitere

Science · 02.04.2026 · 392 (6793)

DOI: 10.1126/science.adv6582 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 02.04.2026. Verfasst von Zhiyuan You und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA. Hauptthemen laut MEDLINE: Dendritic Cells, Mitochondria, Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antitumor immunity requires conventional type 1 dendritic cells (cDC1s). How cDC1s maintain functional fitness in the tumor microenvironment remains unclear. In this study, we established that intratumoral cDC1s exhibited discrete mitochondrial states and that OPA1-mediated mitochondrial energy and redox metabolism dictated cDC1 antitumor responses. Mechanistically, OPA1 orchestrated antigen presentation and the CD8 + T cell priming function of cDC1s by promoting nuclear respiratory factor 1 (NRF1) expression and electron transport chain integrity, thereby supporting bioenergetics and NAD + /NADH balance. During tumor progression, mitochondrial membrane potential and volume, as well as OPA1-NRF1 signaling, declined in intratumoral cDC1s. Furthermore, intratumoral administration of cDC1s with polarized mitochondria showed immunotherapeutic benefits in mice, particularly in combination with immune checkpoint blockade. Collectively, our findings reveal mitochondrial metabolism and signaling as putative targets to reinvigorate cDC1 function for cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsMitochondriaNeoplasmsAnimalsMiceSignal TransductionTumor MicroenvironmentCD8-Positive T-LymphocytesGTP PhosphohydrolasesMice, Inbred C57BLEnergy MetabolismImmunotherapyAntigen PresentationMembrane Potential, MitochondrialCell Line, TumorOxidation-ReductionNAD

Substanzen

Opa1 protein, mouseGTP PhosphohydrolasesNAD

Autor:innen und Institutionen

  • Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Cell and Tissue Imaging Center, St. Jude Children's Research Hospital, Memphis, TN, USA.

ORCID-Profile: Zhiyuan You, Jiyeon Kim, Nicole M Chapman, Xiaoxi Meng, Hao Shi, Yan Wang, Cliff Guy, Jordy Saravia, Gustavo Palacios, Camenzind G Robinson, Hongbo Chi

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • NIH
  • National Institutes of Health CGR

Zitieren

APA

You, Z., Kim, J., Guo, C., Hu, H., Chapman, N. M., Meng, X., Shi, H., Wang, Y., Guy, C., Kc, A., Li, J., Saravia, J., Palacios, G., Rankin, S., Robinson, C. G., & Chi, H. (2026). Mitochondrial metabolism and signaling direct dendritic cell function in antitumor immunity. Science, 392(6793). https://doi.org/10.1126/science.adv6582

Vancouver

You Z, Kim J, Guo C, Hu H, Chapman NM, Meng X, et al. Mitochondrial metabolism and signaling direct dendritic cell function in antitumor immunity. Science. 2026;392(6793). doi:10.1126/science.adv6582

BibTeX
@article{You2026,
  author = {You, Zhiyuan and Kim, Jiyeon and Guo, Chuansheng and Hu, Haoran and Chapman, Nicole M and Meng, Xiaoxi and Shi, Hao and Wang, Yan and Guy, Cliff and Kc, Anil and Li, Jia and Saravia, Jordy and Palacios, Gustavo and Rankin, Sherri and Robinson, Camenzind G and Chi, Hongbo},
  title = {Mitochondrial metabolism and signaling direct dendritic cell function in antitumor immunity},
  journal = {Science},
  year = {2026},
  volume = {392},
  number = {6793},
  doi = {10.1126/science.adv6582}
}
Kostenlos starten →